Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.1M Sell
8,824
-1,048
-11% -$374K 0.13% 106
2025
Q4
$3.23M Buy
9,872
+8,785
+808% +$2.79M 0.11% 113
2025
Q3
$307K Sell
1,087
-73
-6% -$21.2K 0.02% 234
2025
Q2
$324K Sell
1,160
-445
-28% -$126K 0.02% 194
2025
Q1
$500K Buy
1,605
+63
+4% +$18.6K 0.03% 151
2024
Q4
$402K Buy
1,542
+434
+39% +$129K 0.03% 172
2024
Q3
$357K Buy
1,108
+44
+4% +$14.4K 0.02% 164
2024
Q2
$332K Sell
1,064
-32
-3% -$9.4K 0.03% 142
2024
Q1
$312K Sell
1,096
-153
-12% -$44.8K 0.02% 157
2023
Q4
$360K Buy
1,249
+32
+3% +$8.72K 0.03% 135
2023
Q3
$327K Buy
1,217
+16
+1% +$3.99K 0.03% 132
2023
Q2
$267K Sell
1,201
-120
-9% -$27.8K 0.02% 150
2023
Q1
$319K Buy
+1,321
New +$324K 0.04% 141

Other funds holding AMGN

BIP Wealth's AMGN Position: Q1 2026 in Review

BIP Wealth reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $374K and leaving 8,824 shares worth $3.1M. The position accounts for 0.13% of the portfolio, ranked #106.

BIP Wealth first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.23M in Q4 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • BIP Wealth held 8,824 shares of Amgen worth $3.1M as of Q1 2026.
  • BIP Wealth sold 1,048 Amgen shares in Q1 2026, an estimated $374K.
  • Amgen made up 0.13% of BIP Wealth's portfolio in Q1 2026, its #106 holding.
  • BIP Wealth first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
  • BIP Wealth's Amgen position peaked at $3.23M in Q4 2025.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on BIP Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.